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Tbjective: The maze procedure is recognized as the most effective surgical treat-
ent of atrial fibrillation. In the last few years, new surgical ablation techniques
ere developed involving the left atrium only and modifications of the maze
rocedure in ablating both atria. For this study, we evaluated the evidence regarding
he effectiveness of the surgical ablation procedures (biatrial and left atrial) in
educing postoperative atrial fibrillation and subsequent survival.
ethods: MEDLINE was searched for English-language studies using the terms
maze,” “atrial fibrillation,” and “surgical treatment” for 1995 through August 2005.
rimary outcomes of interest were postoperative survival and postoperative freedom
rom atrial fibrillation. Survival data were collected at 1-, 2-, and 3-year intervals.
reedom from atrial fibrillation was collected at 3 months and at 1-, 2-, and 3-year
ntervals.
esults: Sixty-nine studies were included in this analysis. Five thousand eight
undred eighty-five total patients were involved. Patients undergoing surgical
blation (range, 90.4-85.4) demonstrated significantly greater rates of freedom from
trial fibrillation compared with those seen in control patients (range, 47.2-60.9).
urvival rates among patients with biatrial surgical procedures (range, 94.9-92.8)
ere similar to those who had left atrial procedures only (range, 93.9-89.4).
owever, patients undergoing biatrial ablation (range, 92.0-87.1 vs 86.1-73.4)
emonstrated superior freedom from atrial fibrillation at all time points.
onclusion: Biatrial ablation surgical procedures were more effective in controlling
trial fibrillation than procedures confined to the left atrium. To encourage the use
f future meta-analysis within the surgical literature, we suggest the more frequent
eporting of either through Kaplan-Meier survival analyses and the reporting of rates
or specific time intervals.
he maze procedure is recognized as the most effective surgical treatment of
atrial fibrillation (AF). Introduced in 1987 by J. L. Cox as a stand-alone
procedure, the maze procedure has undergone 4 iterations, with each suc-
essfully replacing the previous one.
To our knowledge, there have been no systematic reviews or meta-analyses to
stimate and compare the efficacy of the maze procedure and any other biatrial
urgical procedure with that of procedures limited to the left atrium in the elimi-
ation of AF. The goal of this study is to assess the evidence regarding the
ffectiveness of the different surgical ablation techniques in eliminating postoper-
tive recurrent AF. In addition, we report postoperative survival rates for 1, 2, and
years.
ethods
earch Strategy
e searched MEDLINE for studies in English using the terms “maze,” “atrial fibrillation,”nd “surgical treatment” for the period of 1995 through March 2005. We eliminated any case
he Journal of Thoracic and Cardiovascular Surgery ● Volume 131, Number 5 1029
rt
r
t
d
S
E
i
a
o
m
w
s
d
m
b
s
d
a
a
3
s
f
b
s
C
c
W
w
g
t
c
R
S
S
s
i
(
(
A
c
d
i
“
c
c
o
t
c
p
S
S
s
s
d
p
a
t
[
u
p
2
e
h
r
t
P
P
s
b
3
2
9
f
s
3
d
s
P
W
l
(
a
t
s
T
T
S
C
B
L
Surgery for Acquired Cardiovascular Disease Barnett and Ad
1
A
CDeports or articles focusing on electronic advances in the surgical
reatment of AF. Four studies were eliminated because they rep-
esented the same patient group. Studies were then reviewed a final
ime by each author to ensure the search criteria were met and
esired clinical data were included.1-69
tatistical Methods
ach author then reviewed each report to dichotomize every study
nto temporal categories of “retrospective” or “prospective” and to
ssign study sample sizes to one of 3 size categories on the basis
f the sample of surgical patients in each study: small (50),
edium (51-100), or large (100). The individual author results
ere then compared, and differences in interpretation were re-
olved. Included studies reflected surgeon preference for the use of
ifferent procedures: the use of some studies using the standard
aze procedure lesion set and others using different protocols for
iatrial and left atrial lesion sets only. Thus we defined included
urgical ablation procedures as either biatrial or left atrial proce-
ures only.
The primary outcomes of interest were postoperative survival
nd postoperative freedom from AF. Survival data were collected
t 1-, 2-, and 3-year intervals. Freedom from AF was collected at
months and at 1-, 2-, and 3-year intervals. In the event that a
tudy involved multiple control groups, control group survival and
reedom from AF estimates were combined into one control group
y using weighted averages, with the respective control group
ample sizes serving as the weights.
Effect sizes for all end points were calculated by using the
ohen d statistic.70 Variance estimates for all end points were
alculated by using the method of Hunter and Schmidt.71
eighted postoperative survival and freedom from AF estimates
ere analyzed, with the respective study surgical group or control
roup sample sizes used as the weights. The Student t test was used
o test for statistical significance. All statistical analyses were
onducted with SAS (version 8.12; SAS, Cary, NC) software.
esults
tudies
ixty-nine studies were included in this analysis. Biatrial
urgical ablation procedures accounted for 67% of all stud-
es, and 75% were retrospective in nature. Small studies
50 subjects) comprised almost one half of all studies
42%). Only 14 (19%) studies involved control groups.
verage patient follow-up was 22.9 months. Primary indi-
ation for surgical intervention was prolonged AF, usually
efined as “chronic,” generally presented in tabular format
n the Results section or defined earlier as “chronic” or
persistent” AF lasting more than 6 or 12 months. Electro-
ardiography, Holter monitoring, echocardiography, or
ombinations of these were primarily used to define post-
Abbreviations and Acronyms
AF atrial fibrillationperative freedom from AF. Several reports relied on pa- l
030 The Journal of Thoracic and Cardiovascular Surgery ● Maient self-report during follow-up, but electrocardiographic
onfirmation was then obtained. Freedom from AF end
oints was primarily defined as a return to sinus rhythm.
amples Size
ample sizes for selected studies averaged 85.3 (74.9 for
ubjects undergoing surgical ablation and 51.3 for control
ubjects, Table 1). Studies with the biatrial ablation proce-
ure averaged 73.3 subjects, and studies with left atrial
rocedures averaged 67.3 subjects. Sample sizes for which
control group was involved generally included more con-
rol subjects compared with surgical patients (average, 51.3
range, 10-227] vs 37.1 [range, 5-103]).
When stratified by lesion, studies involved more patients
ndergoing biatrial ablation (88.0  60.1) compared with
atients undergoing left atrial ablation (79.9  67.1, Table
). When stratified by temporal score, prospective studies
nrolled fewer total subjects (57.8  40.4) and almost one
alf as many surgical patients (45.0  32.7) compared with
etrospective studies (94.3  65.6 and 84.7  63.5, respec-
ively; Table 2).
atient Survival and Freedom from AF, All Patients
atients undergoing surgical ablation demonstrated similar
urvival rates compared with those of control patients (Ta-
le 3). At 1, 2, and 3 years, control subjects demonstrated a
% improvement in survival. However, at 3 months and 1,
, and 3 years, patients undergoing surgical ablation (range,
0.4%-85.4%) demonstrated significantly greater rates of
reedom from AF compared with those seen in control
ubjects (range, 47.2%-60.9%). With the exception of the
-year end point, surgical patients nearly doubled the free-
om from AF rate compared with that seen in control
ubjects.
atient Survival and Freedom From AF by Lesion
hen stratified by lesion (biatrial lesions vs left atrial
esions only), survival rates among biatrial surgical patients
range, 94.9%-92.8%) were similar to those among left
trial surgical patients (range, 93.9%-89.4%; Table 4). Bia-
rial surgical patients (range, 92.0%-87.1%) demonstrated
uperior freedom from AF at all time points compared with
ABLE 1. Average sample size
Parameter
No. of
studies
Mean no. of
patients
Standard
deviation Range
otal no. of subjects 69 85.3 62.1 10-276
urgical subjects only 69 74.9 59.8 5-276
ontrol subjects only 14 51.3 57.2 10-227
iatrial sample size 47 73.3 61.3 5-276
eft atrial sample size 24 67.3 58.2 13-234eft atrial surgical patients (range, 86.1%-73.4%).
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CDatient Survival and Freedom From AF by
emporal Score
hen stratified by temporal score, both prospective and
etrospective studies demonstrated similar survival rates at
, 2, and 3 years (Table 5), with prospective studies slightly
etter (range of 95.2%-96.1% vs range of 94.3%-91.9%).
etrospective studies, however, demonstrated increased
ates of freedom from AF (range of 91.4%-87.3% vs range
f 86.3%-79.4%).
iscussion
he use of meta-analyses to summarize research is not a
ovel approach but is still a vastly underused research tool.
deally, investigators would pool individual data from mul-
iple studies under various hypotheses either similar or
dentical to those of their original respective study. Usually,
owever, results from published reports are abstracted
hrough the use of statistics on the basis of sampling meth-
ds.70,71 Results are pooled, and effect sizes can then be
enerated as if all studies were generated from one large
ypothetical patient population, with each study acting as a
ABLE 2. Average sample size by lesion and temporal sco
Biatrial
No. of
studies Mean  SD Ran
otal subjects 46 88.0 60.1 10-2
urgical subjects 46 79.0 59.6 10-2
ontrol subjects 10 41.3 31.1 10-9
Prospective
otal subjects 17 57.8 40.4 24-1
urgical subjects 17 45.0 32.7 10-1
ontrol subjects 7 31.0 26.2 10-8
LA sample size 13 45.8 35.1 10-1
A sample size 5 33.8 20.5 21-7
D, Standard deviation; BLA, bilateral; LA, left atrial.
ABLE 3. Average weighted reported postoperative surviv
Surgical subjects
No. of
studies
Total
sample
size Mean 
-y survival 52 3841 94.5
-y survival 18 1313 94.1
-y survival 17 1338 92.5
-mo freedom from AF 39 2742 90.4
-y freedom from AF 37 3225 84.5
-y freedom from AF 21 1739 84.3
-y freedom from AF 18 1801 85.4D, Standard deviation; AF, atrial fibrillation. *Sample weighted mean and corr
The Journal of Thoracicnique sample from that hypothetical population. The liter-
ture addressing the surgical treatment for AF now has
ozens of studies on various populations from various
ighly regarded surgical groups, all producing excellent
esults. In this report we present the results of what we
elieve to be the first large-scale meta-analysis designed to
valuate the efficacy of surgical ablation as a treatment for
he elimination of AF.
Our results suggest that both surgical groups with and
ithout ablation experience nearly identical postoperative
urvival rates and superior freedom from AF rates at 3
onths and 1, 2, and 3 years. Furthermore, among surgical
atients, biatrial ablation procedures were similar to left
trial ablation–only procedures in postoperative survival
nd superior in freedom from AF rates. The higher success
ate in ablating AF by applying the maze procedure or any
ther biatrial surgical modification is not surprising. Review
f the current literature that discusses the electrophysiology
f AF reveals that there are quite a few different mechanism
uggested, from simple mechanisms pointing to the pulmo-
Left atrial
P value
No. of
studies Mean  SD Range
23 79.9 67.1 13-234 .312
23 66.6 60.5 5-234 .210
4 76.3 100.6 19-227 .247
Retrospective
52 94.3 65.6 10-276 .003
52 84.7 63.5 5-276 .001
7 71.6 73.8 10-227 .085
34 83.8 65.2 5-276 .005
19 76.2 62.0 13-234 .006
d freedom from recurrent atrial fibrillation, all patients
Control subjects
P value
No. of
studies
Total
sample size Mean  SD*
11 429 97.8  0.0 .001
5 299 97.7 0.0 .001
6 334 95.1 0.0 .001
7 236 47.2 17.2 .001
10 312 30.8 19.6 .001
5 181 39.7 21.6 .001
6 514 60.9 31.0 .013re
ge
76
76
7
74
32
7
32
0al an
SD*
0.0
0.0
0.0
6.0
10.3
5.9
5.3ected standard deviation.
and Cardiovascular Surgery ● Volume 131, Number 5 1031
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CDary veins as the source of the arrhythmia to a more com-
lex pattern showing that pathophysiology is more complex
nd biatrial.72,73
A better understanding for the possible reason for the
ifferences in the mechanisms is important. Unfortunately,
o some extent, our ability to do so is presently limited. In
ABLE 4. Average weighted reported postoperative surviv
Biatrial
No. of
studies
Total
sample
size Mean
urgical subjects
1-y survival 32 2391 94.9
2-y survival 14 1159 94.2
3-y survival 13 1136 92.8
3-mo freedom from AF 23 1985 92.0
1-y freedom from AF 24 2260 88.9
2-y freedom from AF 15 1523 85.8
3-y freedom from AF 16 1684 87.1
ontrol subjects
1-y survival 9 378 97.9
2-y survival 5 299 97.7
3-y survival 6 334 95.1
3-mo freedom from AF 5 185 48.3
1-y freedom from AF 7 234 32.8
2-y freedom from AF 4 149 35.4
3-y freedom from AF 5 287 53.1
D, Standard deviation; AF, atrial fibrillation. *Sample weighted mean and
ABLE 5. Average weighted reported postoperative surviv
core
Prospective
No. of
studies
Total
sample
size Mean
urgical subjects
1-y survival 13 560 95.2
2-y survival 4 234 99.4
3-y survival 2 157 96.1
3-mo freedom from AF 10 459 86.3
1-y freedom from AF 10 459 85.1
2-y freedom from AF 10 459 70.1
3-y freedom from AF 2 168 79.4
ontrol subjects
1-y survival 7 217 96.5
2-y survival 1 87 100.0
3-y survival 1 87 100.0
3-mo freedom from AF 5 168 44.4
1-y freedom from AF 7 217 31.4
2-y freedom from AF 2 66 31.1
3-y freedom from AF 1 87 25.6D, Standard deviation; AF, atrial fibrillation. *Sample weighted mean and corr
032 The Journal of Thoracic and Cardiovascular Surgery ● Mahis study the results with the biatrial approach were supe-
ior to those achieved with left atrial ablation only. This
ight be related to the fact that the surgical patients usually
resented with other cardiac pathologies, such as mitral
alve and coronary artery disease, and with long duration of
F. As a result, the disease process in the surgical group of
d freedom from recurrent atrial fibrillation by lesion
Left Atrial
P valueD*
No. of
studies
Total
sample
size Mean  SD*
0 20 1450 93.9 0.0 .999
0 4 154 92.8 0.0 .999
0 3 148 89.4 0.0 .500
0 16 757 86.1 8.4 .001
2 13 965 75.9 8.4 .001
0 6 216 74.5 1.9 .001
7 2 117 73.4 0.0 .001
0 2 51 97.4 0.0 .999
0 — — — —
0 — — — —
.9 2 51 43.2 24.2 .076
.4 3 78 26.8 21.5 .014
.5 1 32 66.2 0.0 .001
.5 1 227 78.8 0.0 .001
ected standard deviation.
nd freedom from recurrent atrial fibrillation by temporal
Retrospective
P valueD*
No. of
studies
Total
sample
size Mean  SD*
.0 39 3281 94.3 0.0 .900
.0 14 1079 92.8 0.0 .003
.0 14 1127 91.9 0.0 .956
.4 29 2283 91.4 5.8 .003
.7 27 2735 84.8 9.7 .375
.7 14 1395 85.2 5.3 .072
.0 16 1633 87.3 5.3 .095
.0 4 212 97.1 0.0 .990
.0 4 212 96.6 0.0 .995
.0 5 247 93.1 0.0 .995
6.9 2 68 54.9 15.6 .001
6.9 3 95 30.0 23.5 .300
8.5 3 115 44.2 15.2 .242
.0 5 427 71.3 27.7 .003al an
 S
 0.
 0.
 0.
 4.
 8.
 5.
 4.
 0.
 0.
 0.
 14
 18
 20
 34al a
 S
 0
 0
 0
 4
 3
 5
 0
 0
 0
 0
 1
 1
 2
 0ected standard deviation.
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A
CDatients is much more advanced and diffuse when compared
ith that of patients treated with catheter pulmonary vein
blation for lone AF. Given that most mapping data for AF
re based on nonsurgical patients with lone AF, it would be
ifficult to speculate about the exact mechanism among
urgical patients to further support either surgical approach.
apping during surgical intervention has the potential to
uide surgeons to more specific ablation protocols. How-
ver, at this time, few clinical studies have assessed this
trategy.
There are some reports documenting greater permanent
acemaker implantation after the maze procedure compared
ith that after left atrial ablation only. The indication for
acemaker use is sinus node dysfunction in most cases. The
ajority of patients with sinus node activity recover to the
xtent that patients are no longer pacemaker dependent.74
owever, except for among patients after the maze I pro-
edure, sinus node dysfunction cannot be attributed to the
urgical procedure. It might be due to the fact that there is
higher success rate in ablating AF and that more cases of
ick sinus syndrome that are strongly associated with AF are
iscovered.
Our study has several strengths and limitations. To our
nowledge, this is the first attempt to systematically analyze
ublished data for the surgical treatment of AF. We have
onducted an extensive search for all clinical studies meet-
ng our search criteria. However, publication bias might
ave eliminated potential studies for whatever reason
eemed important by various editorial boards, and although
here is no formal way to test for this, we would be remiss
f we did not caution the readers of this potential for bias. In
ddition, determining rates of survival and freedom from
ostoperative AF was sometimes accomplished by viewing
ctual Kaplan-Meier curves and extrapolating results. This
ight have led to some discrepancies from the true pub-
ished results. However, given the ease of reading a Kaplan-
eier plot, we think this is a minimal concern. Furthermore,
ur study included all studies relevant to our search strategy.
We made no attempt to exclude studies on the basis of
ize, degree of follow-up, or definition of AF. This might
ave biased our findings, but we have attempted to portray
s general and inclusive a review of the literature as possi-
le. The inclusion of different study groups might have
iased the effects of any subgroup analysis, but we believe
his effect could be minimal because of the consistent pro-
le of patients referred for a surgical ablation procedure.
tudies involving shorter follow-up might have ended be-
ore a return to dysrhythmia, thereby indicating artificially
igh rates of freedom from AF. Unfortunately, the tradi-
ional strengths of meta-analyses involving clinical trials are
otential limitations for our study. Those meta-analyses
ave very defined patient groups from which a meta-anal-
sis can be performed. There are few clinical trials involv-
The Journal of Thoracicng our subject matter, leaving us with retrospective trials
rom which patient groups were undoubtedly more hetero-
eneous. With this in mind, we have attempted to give the
nterested reader a composite view of the existing research
egarding surgical treatment for AF.
We caution the reader that this is a summary of published
esults. We did not have access to original data, and thus
rrors might have occurred in our extrapolation of data from
aplan-Meier tables, in the combination of multiple control
roups into one group through weighting, and in the poten-
ial temporal bias of using data over an 11-year span.
urgical ablation expertise and technique have no doubt
aused increases in both survival and freedom from AF
ates. Furthermore, freedom from AF as a study end point
as generally defined as a return to sinus rhythm, with no
dditional detail. It is possible that a different patient pop-
lation would have provided different freedom from AF
ates under different investigator protocols.
This summary review suggests the surgical treatment for
F offers similar postoperative survival rates and vastly
uperior freedom from AF rates compared with those of
raditional therapies. In addition, the surgical treatment of
F involving biatrial status offers superior long-term sur-
ival and freedom from AF.
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